cent of total deaths across all age groups in 2012. Cancer, diabetes and non-communicable variants of respiratory diseases contributed three per cent, two per cent and one per cent to total mortality, respectively (2012). Injuries accounted for ten per cent of deaths in 2012. The most commonly diagnosed mental illnesses in Nigeria are mood disorders. Health systems: In 2012 government expenditure on health was 1.9 per cent of GDP, equivalent to US$29 per capita. In the most recent survey, conducted between 1997 and 2010, there were 40 doctors, and 161 nurses and midwives per 100,000 people. Additionally, in 2013, 38 per cent of births were attended by qualified health staff and in 2013, 59 per cent of one-year-olds were immunised with one dose of measles. In 2012, 64 per cent of people were using an improved drinking water source and 28 per cent had access to adequate sanitation facilities. The most recent survey, conducted in the period 2000–11, reports that Nigeria has 11 pharmaceutical personnel per 100,000 people. Under-five mortality 250 200 150 100 1990 1995 2000 2005 2010 2015 Under-five mortality per 1,000 live births 2015 MDG 4 target 50 Life expectancy and HIV/AIDS 60 50 4.0 3.5 3.0 2.5 2.0 1.5 1980 1990 2000 2013 Prevalence of HIV/AIDS among those aged 15–49 Life expectancy Prevalence of HIV, total (% of population aged 15-49) Life expectancy in years 40 1.0 New BSL-3 laboratory at NVRI, established with the support of the Department of Foreign and International Trade, Canada What began in 1924 as a small laboratory for the production of anti-serum to control the deadly rinderpest scourge in cattle, has today grown into a renowned institution, with a wide mandate for animal disease surveillance and control, research and animal vaccine development and production. Research projects include those on the highly pathogenic avian influenza (HPAI) virus in Nigeria, foot-and-mouth disease (FMD), contagious bovine pleuro pneumonia (CBPP), peste des petits ruminants (PPR), African swine fever (ASF), brucellosis and anthrax. Other research programmes include the development of multivalent vaccines for the control of poultry diseases such as salmonellosis, and the development of a killed, adjuvanted rabies cell culture vaccine. These projects are supported by partners including FAO, OIE, DFID, EU and the Canadian government. NVRI also produces ethno-veterinary products from local herbs for the control of skin infections in both animals and humans. Some of these products have been certified and are ready for commercial production while others are undergoing clinical and toxicity trials. These research programmes have been designed to deliver on the mandate and the mission of NVRI. The key to the success of meeting the mandate is continued selfregulation and peer review to ensure that research is demand driven and generates technologies that will solve farmers’ problems. The huge demand for animal vaccines and disease surveillance and control has meant that high quality research is also continuous. National Veterinary Research Institute, Vom Nigeria Dr Mohammed Sani Ahmed DVM, MPVM, PhD, FCVSN, Executive Director www.nvri.gov.ng
Commonwealth Health Partnerships 2015
To see the actual publication please follow the link above